ATE80796T1 - Therapeutisches proteinagens in form von aerosol. - Google Patents

Therapeutisches proteinagens in form von aerosol.

Info

Publication number
ATE80796T1
ATE80796T1 AT88303909T AT88303909T ATE80796T1 AT E80796 T1 ATE80796 T1 AT E80796T1 AT 88303909 T AT88303909 T AT 88303909T AT 88303909 T AT88303909 T AT 88303909T AT E80796 T1 ATE80796 T1 AT E80796T1
Authority
AT
Austria
Prior art keywords
therapeutic protein
aerosol form
protein agent
agent
aerosol
Prior art date
Application number
AT88303909T
Other languages
English (en)
Inventor
Nicolaas J Roosdorp
Ronald G Crystal
Original Assignee
Cooper Lab
Ronald G Crystal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cooper Lab, Ronald G Crystal filed Critical Cooper Lab
Application granted granted Critical
Publication of ATE80796T1 publication Critical patent/ATE80796T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT88303909T 1987-04-30 1988-04-29 Therapeutisches proteinagens in form von aerosol. ATE80796T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4444687A 1987-04-30 1987-04-30
EP88303909A EP0289336B1 (de) 1987-04-30 1988-04-29 Therapeutisches Proteinagens in Form von Aerosol

Publications (1)

Publication Number Publication Date
ATE80796T1 true ATE80796T1 (de) 1992-10-15

Family

ID=21932433

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88303909T ATE80796T1 (de) 1987-04-30 1988-04-29 Therapeutisches proteinagens in form von aerosol.

Country Status (8)

Country Link
US (1) US5618786A (de)
EP (1) EP0289336B1 (de)
JP (1) JP2656944B2 (de)
AT (1) ATE80796T1 (de)
CA (1) CA1327309C (de)
DE (1) DE3874798T2 (de)
ES (1) ES2035920T3 (de)
GR (1) GR3006427T3 (de)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05963A (ja) * 1990-04-13 1993-01-08 Toray Ind Inc ポリペプチド類組成物
DE69123960T2 (de) † 1990-10-16 1997-05-07 John Lezdey Behandlung von entzündungen
DE4117078A1 (de) * 1991-05-25 1992-11-26 Boehringer Ingelheim Kg Verfahren zur herstellung therapeutisch anwendbarer aerosole
RU2054180C1 (ru) * 1991-08-21 1996-02-10 Жирнов Олег Петрович (н/п) Способ лечения вирусных респираторных инфекций
US6673335B1 (en) * 1992-07-08 2004-01-06 Nektar Therapeutics Compositions and methods for the pulmonary delivery of aerosolized medicaments
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US6509006B1 (en) 1992-07-08 2003-01-21 Inhale Therapeutic Systems, Inc. Devices compositions and methods for the pulmonary delivery of aerosolized medicaments
GB9215109D0 (en) * 1992-07-16 1992-08-26 Univ Sheffield Magnetic materials and method of making them
CZ286632B6 (cs) * 1992-09-29 2000-05-17 Inhale Therapeutic Systems Farmaceutický prostředek
US5354934A (en) † 1993-02-04 1994-10-11 Amgen Inc. Pulmonary administration of erythropoietin
FR2711523B1 (fr) * 1993-10-26 1996-02-16 Transgene Sa Procédé de préparation d'un aérosol viral.
EP1462096B1 (de) 1994-03-07 2008-12-10 Nektar Therapeutics Verfahren und Zusammensetzung für die pulmonale Darreichung von Insulin
US20030113273A1 (en) * 1996-06-17 2003-06-19 Patton John S. Methods and compositions for pulmonary delivery of insulin
CN1073119C (zh) * 1994-05-18 2001-10-17 吸入治疗系统公司 干扰素干粉配方的方法及组合物
US6729334B1 (en) 1994-06-17 2004-05-04 Trudell Medical Limited Nebulizing catheter system and methods of use and manufacture
NZ272354A (en) * 1994-06-17 1997-10-24 Trudell Medical Ltd Catheter system; method and apparatus for delivering an aerosol form of medication to the lungs, details of method and of catheter apparatus
US5642730A (en) * 1994-06-17 1997-07-01 Trudell Medical Limited Catheter system for delivery of aerosolized medicine for use with pressurized propellant canister
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
US5780014A (en) * 1995-04-14 1998-07-14 Inhale Therapeutic Systems Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
US20060025348A1 (en) * 1997-05-28 2006-02-02 Pilon Aprile L Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production
US20060281681A1 (en) * 1997-05-28 2006-12-14 Pilon Aprile L Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease
US6255281B1 (en) * 1997-05-28 2001-07-03 Claragen, Inc. And U.S. Government Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
US20030035778A1 (en) * 1997-07-14 2003-02-20 Robert Platz Methods and compositions for the dry powder formulation of interferon
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6309623B1 (en) * 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6660715B2 (en) * 1998-11-19 2003-12-09 Massachusetts Institute Of Technology Nonaqueous solutions and suspensions of macromolecules for pulmonary delivery
US6156294A (en) 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US6676930B2 (en) 1999-11-28 2004-01-13 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US7871598B1 (en) * 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
DK1280520T4 (en) 2000-05-10 2018-06-25 Novartis Ag Phospholipid based powders for drug delivery
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US20030072717A1 (en) 2001-02-23 2003-04-17 Vapotronics, Inc. Inhalation device having an optimized air flow path
AU2002325108A1 (en) * 2001-08-27 2003-03-10 Les Laboratoires Aeterna Inc. Serine protease inhibitor and processes for the preparation thereof
US7176278B2 (en) 2001-08-30 2007-02-13 Biorexis Technology, Inc. Modified transferrin fusion proteins
WO2003053411A1 (en) 2001-12-19 2003-07-03 Nektar Therapeutics Pulmonary delivery of aminoglycosides
US7419801B2 (en) * 2003-08-08 2008-09-02 Arriva Pharmaceuticals, Inc. Methods of protein production in yeast
DK1684719T3 (da) * 2003-11-14 2012-01-30 Baxter Int Alfa-1-antitrypsin-sammensætninger og behandlingsfremgangsmåder, der anvender sådanne sammensætninger
CA2559062A1 (en) * 2004-03-09 2005-09-22 Arriva Pharmaceuticals, Inc. Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitor
IL163453A0 (en) * 2004-08-10 2009-02-11 Yeda Res & Dev Enzyme inhibitor in leukemia
US20070105768A1 (en) * 2004-11-10 2007-05-10 Rajiv Nayar Dry recombinant human alpha 1-antitrypsin formulation
BRPI0707635A2 (pt) * 2006-02-09 2011-05-10 Kamada Ltd liberaÇço pulmonar de inibidor de alfa-1 proteinase
EP2077132A1 (de) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Abgabevorrichtung, Aufbewahrungsvorrichtung und Verfahren zur Abgabe einer Formulierung
MX2010012234A (es) 2008-05-13 2011-03-03 Clarassance Inc Cc10 humana recombinante y composiciones del mismo para uso en el tratamiento de rinitis nasal.
EP2414560B1 (de) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Verfahren zur beschichtung einer oberfläche eines bauteils
JP5763053B2 (ja) 2009-05-18 2015-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング アダプタ、吸入器具及びアトマイザ
US9168285B2 (en) 2009-10-15 2015-10-27 Therabron Therapeutics, Inc. Recombinant human CC10 protein for treatment of influenza and ebola
BR112012008463A2 (pt) 2009-10-15 2019-09-24 Clarassance Inc proteína recombinante humana cc10 para tratamento de gripe
PE20130036A1 (es) 2009-11-25 2013-02-03 Boehringer Ingelheim Int Nebulizador
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
US9943654B2 (en) 2010-06-24 2018-04-17 Boehringer Ingelheim International Gmbh Nebulizer
RU2425691C1 (ru) * 2010-07-15 2011-08-10 ВАКЕ спол с.р.о. Аэрозольный препарат на основе апротинина для лечения вирусных респираторных инфекций
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
RU2657523C2 (ru) * 2011-11-03 2018-06-14 Олег Петрович Жирнов Фармацевтический аэрозольный состав ингибиторов протеаз с озон-сберегающим пропеллентом и его получение
SG10201610913PA (en) 2011-12-30 2017-02-27 Grifols Sa Alpha1-proteinase inhibitor for delaying the onset or progression of pulmonary exacerbations
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
EP3030298B1 (de) 2013-08-09 2017-10-11 Boehringer Ingelheim International GmbH Vernebler
EP2835146B1 (de) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Zerstäuber
HUE055604T2 (hu) 2014-05-07 2021-12-28 Boehringer Ingelheim Int Porlasztó
WO2015169732A1 (en) 2014-05-07 2015-11-12 Boehringer Ingelheim International Gmbh Container, nebulizer and use
AP2016009486A0 (en) 2014-05-07 2016-10-31 Boehringer Ingelheim Int Nebulizer, indicator device and container
PL3723790T3 (pl) 2017-12-12 2024-05-13 Kamada Ltd Sposoby indukowania tolerancji immunologicznej i redukcji odpowiedzi przeciwciała antylekowego

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3642981A (en) * 1970-05-04 1972-02-15 Us Army Toxic chemical vaccines
DE2254061A1 (de) * 1972-11-04 1974-05-16 Hoechst Ag Lh-releasing hormon zur nasalen applikation
GB1454105A (en) * 1972-11-04 1976-10-27 Hoechst Ag Preparation containing luteinizing hormone-releasing factor
JPS56128721A (en) * 1980-03-12 1981-10-08 Eisai Co Ltd Antiallergic agent
JPS57144224A (en) * 1981-03-02 1982-09-06 Mochida Pharmaceut Co Ltd Remedy for respiratory dieseases
AU577259B2 (en) * 1982-08-13 1988-09-22 Zymogenetics Inc. Glycolytic promters for regulated protein expression protease inhibitor
DE3230275A1 (de) * 1982-08-14 1984-02-16 Bayer Ag, 5090 Leverkusen Elastaseinhibitoren, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel
AU560584B2 (en) * 1983-07-28 1987-04-09 Bayer Aktiengesellschaft Homologues of aprotinin
US4711848A (en) * 1984-03-14 1987-12-08 Zymogenetics, Inc. Site specific mutagenesis in alpha-1-antitrypsin
US4732973A (en) * 1984-06-14 1988-03-22 Chiron Corporation Active site modified protease α-1-antitrypsin inhibitors
DE3666826D1 (en) * 1985-01-18 1989-12-14 Searle & Co Human natural inhibitor of collagenases
EP0223831B1 (de) * 1985-05-22 1992-07-15 Liposome Technology, Inc. Verfahren und system zum einatmen von liposomen
US4916117A (en) * 1986-12-24 1990-04-10 John Lezdey Treatment of inflammation using alpha 1-antichymotrypsin
US5114917A (en) * 1986-12-24 1992-05-19 John Lezdey Treatment of inflammation using alpha 1-antichymotrypsin
US4997814A (en) * 1988-06-09 1991-03-05 Allelix Biopharmaceuticals, Inc. Pharmaceutical compositions and use thereof in treating inflammation
US5215965A (en) * 1990-10-02 1993-06-01 John Lezdey Treatment of inflammation

Also Published As

Publication number Publication date
EP0289336B1 (de) 1992-09-23
US5618786A (en) 1997-04-08
DE3874798D1 (de) 1992-10-29
JP2656944B2 (ja) 1997-09-24
DE3874798T2 (de) 1993-04-15
CA1327309C (en) 1994-03-01
AU605580B2 (en) 1991-01-17
GR3006427T3 (de) 1993-06-21
EP0289336A3 (en) 1989-10-11
EP0289336A2 (de) 1988-11-02
JPS6434923A (en) 1989-02-06
ES2035920T3 (es) 1993-05-01
AU1532088A (en) 1988-11-03

Similar Documents

Publication Publication Date Title
ATE80796T1 (de) Therapeutisches proteinagens in form von aerosol.
DK0535091T3 (da) Knogleinducerende farmaceutiske formuleringer
ATE224956T1 (de) Verfahren zur verstärkten expression von virusproteinen
ATE173478T1 (de) Varianten des pankreatischen rinder- trypsininhibitors, deren herstellung und verwendung
ATE196428T1 (de) Verwendung von gentisinsäure oder gentisylalkohol zur stabilisierung von radio-markierten peptiden und proteinen
DE68918155D1 (de) Chirurgisches Klebstoffmaterial.
ATE92107T1 (de) N-terminale fragmente von menschliches serumalbumin enthaltenden fusionsproteinen.
NO831317L (no) Fremgangsmaate for fremstilling av funksjonelle menneske-urokinase proteiner.
DE68923123D1 (de) Herstellung von Proteinen.
PT81990B (pt) Processo para a preparacao de derivados peptidicos inibidores da renina e das proteases acidas
ATE148165T1 (de) Stabilisierung von hochgereinigten proteinen
ZA8860B (en) Pancreatic secretory trypsin inhibitor and variants thereof produced by a recombinant host,process,expression vector and recombinant host therefor and pharmaceutical use thereof
ES548617A0 (es) Procedimiento para disociar peptidos y proteinas en el enla-ce metionilo
ES2072490T3 (es) Procedimiento para la pasteurizacion de la proteina tisular pp4.
DE59207095D1 (de) Verfahren zur Herstellung von aktiviertem Protein C
ATE185376T1 (de) Verfahren zur messung von gewebeplasminogenaktivator, antithrombin-iii und lösliches fibrin
ATE115863T1 (de) Verwendung eines immunglobulinhaltigen präparates zur prophylaxe und therapie von aids beim menschen.
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
DE59006998D1 (de) Verfahren zur herstellung von hirudin.
DE59510818D1 (de) Verfahren zur Reaktivierung von gereinigten Membranproteinen durch Einfrieren
DE3771548D1 (de) Verwendung von carbonsaeure in fuer topische anwendung vorgesehenen pharmazeutischen zubereitungen.
FI906112A7 (fi) Menetelmiä ja koostumuksia nisäkkäiden infektioiden käsittelemiseksi k äyttämällä lääkkeitä, jotka käsittävät pistiäisten myrkkyä, sen protei ini- tai polypeptidiainesosia tai näiden porteiini- tai polypeptidiain eosien analogeja
DK563886A (da) Terapeutisk komposition

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee